Theravance Inc news

   Watch this stock
Showing stories 1 - 10 of about 94   

Articles published

THRX 16.87 -0.55 (-3.16%)
price chart
Company Shares of Theravance, Inc. Drops by -12.91%
Theravance, Inc. (NASDAQ:THRX) has lost 12.91% during the past week and dropped 6.43% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 11.87%.
Volatile Theravance Inc. Offers Attractive Total Returns Potential (THRX)
Theravance, Inc. is a royalty management company. The South San Francisco, California-headquartered company is primarily focused on maximizing the potential value of the respiratory assets partnered with United Kingdom-based pharmaceutical giant ...
Analyst Price Target Update on Theravance, Inc.
Theravance, Inc. (NASDAQ:THRX): The mean estimate for the short term price target for Theravance, Inc.
Theravance Short Interest Down 3.4% in June (THRX)  sleekmoney
Inside Trading: James Tyree Unloaded 2438 Shares of Theravance Inc ...
James Tyree, director of Theravance Inc (NASDAQ:THRX) 19.37 +0.09 0.47% is the insider, OctaFinance want to disclose transactions for.
Theravance Inc (THRX) Discloses Form 4 Insider Selling : James L Tyree Sells ...  Money Flow Index
Theravance Receives $17.40 Consensus Target Price from Brokerages ...  WKRB News
Theravance Inc. (NASDAQ:THRX) declared a quarterly dividend
Theravance Inc. (NASDAQ:THRX) declared a quarterly dividend on February 24th, Analyst Ratings News reports. Investors of record on Thursday, March 12th will be paid a dividend of 0.25 per share on Tuesday, March 31st.
Billionaire Klarman's Top Small-Cap Picks: ViaSat Inc., Theravance Inc., PBF ...
The Baupost Group is a Boston-based hedge fund founded and operated by billionaire Seth Klarman. Klarman's fund is one of the biggest and most successful hedge fund firms in the world, ranking fourth in net gains since its founding, according to ...
Analyst Rating Update on Theravance, Inc.
Theravance (NASDAQ:THRX) has received a hold rating for the short term, according to the latest rank of 3 from research firm, Zacks.
Q4 Earnings of $-0.08 Anticipated for Theravance, Inc. (NASDAQ:THRX)
Wall Street analysts expect Theravance, Inc. (NASDAQ:THRX) to report earnings per share of $-0.08 for the current fiscal quarter.
Stock in Motion: Theravance, Inc. (NASDAQ:THRX)
Theravance, Inc. (NASDAQ:THRX) shares opened the most recent trading session at 17.50 and at the time of writing the last Bid was at 16.80.
Theravance, Inc. Price Target Update
Theravance, Inc. (NASDAQ:THRX): The mean short term price target for Theravance, Inc. (NASDAQ:THRX) has been established at $14 per share.
Theravance, Inc. Short Interest Update  OTC Outlook
Stock Update - Theravance, Inc. (NASDAQ:THRX)  Vanguard Tribune